{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T04:14:07Z","timestamp":1782015247472,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00415-026-13747-8","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:37:14Z","timestamp":1773664634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Brivaracetam for status epilepticus: a systematic review"],"prefix":"10.1007","volume":"273","author":[{"given":"Anna","family":"Howard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caralyn","family":"Bencsik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ish","family":"Bains","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Jaworska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8850-9095","authenticated-orcid":false,"given":"Julie","family":"Kromm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"13747_CR1","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/epi.13121","volume":"56","author":"E Trinka","year":"2015","unstructured":"Trinka E, Cock H, Hesdorffer D et al (2015) A definition and classification of status epilepticus \u2013 report of the ILAE task force on classification of status epilepticus. Epilepsia 56:1515\u20131523. https:\/\/doi.org\/10.1111\/epi.13121","journal-title":"Epilepsia"},{"key":"13747_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.neulet.2016.12.044","volume":"667","author":"MC Walker","year":"2018","unstructured":"Walker MC (2018) Pathophysiology of status epilepticus. Neurosci Lett 667:84\u201391. https:\/\/doi.org\/10.1016\/j.neulet.2016.12.044","journal-title":"Neurosci Lett"},{"key":"13747_CR3","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1212\/con.0000000000001103","volume":"28","author":"E Trinka","year":"2022","unstructured":"Trinka E, Leitinger M (2022) Management of status epilepticus, refractory status epilepticus, and super-refractory status epilepticus. Continuum Minneap Minn 28:559\u2013602. https:\/\/doi.org\/10.1212\/con.0000000000001103","journal-title":"Continuum Minneap Minn"},{"key":"13747_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/ana.24606","volume":"79","author":"P Vespa","year":"2016","unstructured":"Vespa P, Tubi M, Claassen J et al (2016) Metabolic crisis occurs with seizures and periodic discharges after brain trauma. Ann Neurol 79:579\u2013590. https:\/\/doi.org\/10.1002\/ana.24606","journal-title":"Ann Neurol"},{"key":"13747_CR5","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1212\/01.wnl.0000063316.47591.b4","volume":"60","author":"PM Vespa","year":"2003","unstructured":"Vespa PM, O\u2019Phelan K, Shah M et al (2003) Acute seizures after intracerebral hemorrhage. Neurology 60:1441\u20131446. https:\/\/doi.org\/10.1212\/01.wnl.0000063316.47591.b4","journal-title":"Neurology"},{"key":"13747_CR6","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1212\/wnl.0b013e3181f07334","volume":"75","author":"PM Vespa","year":"2010","unstructured":"Vespa PM, McArthur DL, Xu Y et al (2010) Nonconvulsive seizures after traumatic brain injury are associated with hippocampal atrophy. Neurology 75:792\u2013798. https:\/\/doi.org\/10.1212\/wnl.0b013e3181f07334","journal-title":"Neurology"},{"key":"13747_CR7","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1097\/01.CCM.0000295667.66853.BC","volume":"35","author":"PM Vespa","year":"2007","unstructured":"Vespa PM, Miller C, McArthur D et al (2007) Nonconvulsive electrographic seizures after traumatic brain injury result in a delayed, prolonged increase in intracranial pressure and metabolic crisis. Crit Care Med 35:2830\u20132836","journal-title":"Crit Care Med"},{"key":"13747_CR8","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/brain\/awu042","volume":"137","author":"ET Payne","year":"2014","unstructured":"Payne ET, Zhao XY, Frndova H et al (2014) Seizure burden is independently associated with short term outcome in critically ill children. Brain 137:1429\u20131438. https:\/\/doi.org\/10.1093\/brain\/awu042","journal-title":"Brain"},{"key":"13747_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","volume":"16","author":"T Glauser","year":"2016","unstructured":"Glauser T, Shinnar S, Gloss D et al (2016) Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society. Epilepsy Curr 16:48\u201361. https:\/\/doi.org\/10.5698\/1535-7597-16.1.48","journal-title":"Epilepsy Curr"},{"key":"13747_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/17511437251321338","volume":"26","author":"R Mullhi","year":"2025","unstructured":"Mullhi R, Hayton T, Midgley-Hunt A et al (2025) Guidance for: the acute management of status epilepticus in adult patients. J Intensive Care Soc 26:249\u2013263. https:\/\/doi.org\/10.1177\/17511437251321338","journal-title":"J Intensive Care Soc"},{"key":"13747_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","volume":"17","author":"GM Brophy","year":"2012","unstructured":"Committee NCSSEGW, Brophy GM, Bell R et al (2012) Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 17:3\u201323. https:\/\/doi.org\/10.1007\/s12028-012-9695-z","journal-title":"Neurocrit Care"},{"key":"13747_CR12","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1056\/nejm199809173391202","volume":"339","author":"DM Treiman","year":"1998","unstructured":"Treiman DM, Meyers PD, Walton NY et al (1998) A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med 339:792\u2013798. https:\/\/doi.org\/10.1056\/nejm199809173391202","journal-title":"N Engl J Med"},{"key":"13747_CR13","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/nejmoa1905795","volume":"381","author":"J Kapur","year":"2019","unstructured":"Kapur J, Elm J, Chamberlain JM et al (2019) Randomized trial of three anticonvulsant medications for status epilepticus. New Engl J Med 381:2103\u20132113. https:\/\/doi.org\/10.1056\/nejmoa1905795","journal-title":"New Engl J Med"},{"key":"13747_CR14","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1177\/1756285616665564","volume":"9","author":"C Brandt","year":"2016","unstructured":"Brandt C, May TW, Bien CG (2016) Brivaracetam as adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy: the current evidence base. Ther Adv Neurol Disord 9:474\u2013482. https:\/\/doi.org\/10.1177\/1756285616665564","journal-title":"Ther Adv Neurol Disord"},{"key":"13747_CR15","doi-asserted-by":"publisher","DOI":"10.1177\/1756285617742081","volume":"11","author":"LJ Stephen","year":"2018","unstructured":"Stephen LJ, Brodie MJ (2018) Brivaracetam: a novel antiepileptic drug for focal-onset seizures. Ther Adv Neurol Disord 11:1756285617742081. https:\/\/doi.org\/10.1177\/1756285617742081","journal-title":"Ther Adv Neurol Disord"},{"key":"13747_CR16","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/epi.13787","volume":"58","author":"J Niquet","year":"2017","unstructured":"Niquet J, Suchomelova L, Thompson K et al (2017) Acute and long-term effects of brivaracetam and brivaracetam\u2013diazepam combinations in an experimental model of status epilepticus. Epilepsia 58:1199\u20131207. https:\/\/doi.org\/10.1111\/epi.13787","journal-title":"Epilepsia"},{"key":"13747_CR17","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1586\/17512433.2016.1156529","volume":"9","author":"A Strzelczyk","year":"2016","unstructured":"Strzelczyk A, Klein KM, Willems LM et al (2016) Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus. Expert Rev Clin Pharmacol 9:637\u2013645. https:\/\/doi.org\/10.1586\/17512433.2016.1156529","journal-title":"Expert Rev Clin Pharmacol"},{"key":"13747_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/epi.13267","volume":"57","author":"J Nicolas","year":"2016","unstructured":"Nicolas J, Hannestad J, Holden D et al (2016) Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action. Epilepsia 57:201\u2013209. https:\/\/doi.org\/10.1111\/epi.13267","journal-title":"Epilepsia"},{"key":"13747_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116799","volume":"413","author":"KMC Moalong","year":"2020","unstructured":"Moalong KMC, Espiritu AI, Fernandez MLL (2020) Efficacy and tolerability of intravenous brivaracetam for status epilepticus: a systematic review. J Neurol Sci 413:116799. https:\/\/doi.org\/10.1016\/j.jns.2020.116799","journal-title":"J Neurol Sci"},{"key":"13747_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"13747_CR21","doi-asserted-by":"publisher","DOI":"10.13105\/wjma.v5.i4.80","volume":"5","author":"C Luchini","year":"2017","unstructured":"Luchini C, Stubbs B, Solmi M, Veronese N (2017) Assessing the quality of studies in meta-analyses: advantages and limitations of the Newcastle Ottawa Scale. World J Meta-Anal 5:80. https:\/\/doi.org\/10.13105\/wjma.v5.i4.80","journal-title":"World J Meta-Anal"},{"key":"13747_CR22","unstructured":"S M, Z M, C T, et al (2020) Chapter 7: systematic reviews of etiology and risk. In: E A, Z M (eds) JBI Manual for Evidence Synthesis"},{"key":"13747_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/wnp.0000000000000806","volume":"38","author":"LJ Hirsch","year":"2021","unstructured":"Hirsch LJ, Fong MWK, Leitinger M et al (2021) American Clinical Neurophysiology Society\u2019s standardized critical care EEG terminology: 2021 version. J Clin Neurophysiol 38:1\u201329. https:\/\/doi.org\/10.1097\/wnp.0000000000000806","journal-title":"J Clin Neurophysiol"},{"key":"13747_CR24","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.yebeh.2015.05.007","volume":"49","author":"M Leitinger","year":"2015","unstructured":"Leitinger M, Beniczky S, Rohracher A et al (2015) Salzburg consensus criteria for Non-Convulsive Status Epilepticus \u2013 approach to clinical application. Epilepsy Behav 49:158\u2013163. https:\/\/doi.org\/10.1016\/j.yebeh.2015.05.007","journal-title":"Epilepsy Behav"},{"key":"13747_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.yebeh.2017.03.028","volume":"70","author":"A Strzelczyk","year":"2017","unstructured":"Strzelczyk A, Steinig I, Willems LM et al (2017) Treatment of refractory and super-refractory status epilepticus with brivaracetam: a cohort study from two German university hospitals. Epilepsy Behav 70:177\u2013181. https:\/\/doi.org\/10.1016\/j.yebeh.2017.03.028","journal-title":"Epilepsy Behav"},{"key":"13747_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2023.109464","volume":"148","author":"C Martellino","year":"2023","unstructured":"Martellino C, Lagan\u00e0 A, Atanasio G et al (2023) The real-world effectiveness of intravenous brivaracetam as a second-line treatment in status epilepticus. Epilepsy Behav 148:109464. https:\/\/doi.org\/10.1016\/j.yebeh.2023.109464","journal-title":"Epilepsy Behav"},{"key":"13747_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2023.109384","volume":"147","author":"V Villanueva","year":"2023","unstructured":"Villanueva V, Rodriguez-Osorio X, Juiz-Fern\u00e1ndez \u00c1 et al (2023) Real-life evidence about the use of intravenous brivaracetam in urgent seizures: the BRIV-IV study. Epilepsy Behav 147:109384. https:\/\/doi.org\/10.1016\/j.yebeh.2023.109384","journal-title":"Epilepsy Behav"},{"key":"13747_CR28","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s40263-023-01039-y","volume":"37","author":"Y Winter","year":"2023","unstructured":"Winter Y, Sandner K, Vieth T et al (2023) Third-generation antiseizure medication in the treatment of Benzodiazepine-Refractory Status Epilepticus in poststroke epilepsy: a retrospective observational register-based study. CNS Drugs 37:929\u2013936. https:\/\/doi.org\/10.1007\/s40263-023-01039-y","journal-title":"CNS Drugs"},{"key":"13747_CR29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.seizure.2021.01.014","volume":"86","author":"N Orlandi","year":"2021","unstructured":"Orlandi N, Bartolini E, Audenino D et al (2021) Intravenous brivaracetam in status epilepticus: a multicentric retrospective study in Italy. Seizure 86:70\u201376. https:\/\/doi.org\/10.1016\/j.seizure.2021.01.014","journal-title":"Seizure"},{"key":"13747_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.eplepsyres.2018.12.001","volume":"149","author":"I Aicua-Rapun","year":"2019","unstructured":"Aicua-Rapun I, Andr\u00e9 P, Rossetti AO et al (2019) Intravenous brivaracetam in status epilepticus: correlation between loading dose, plasma levels and clinical response. Epilepsy Res 149:88\u201391. https:\/\/doi.org\/10.1016\/j.eplepsyres.2018.12.001","journal-title":"Epilepsy Res"},{"key":"13747_CR31","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1111\/epi.16094","volume":"60","author":"E Santamarina","year":"2019","unstructured":"Santamarina E, Carbonell BP, Sala J et al (2019) Use of intravenous brivaracetam in status epilepticus: a multicenter registry. Epilepsia 60:1593\u20131601. https:\/\/doi.org\/10.1111\/epi.16094","journal-title":"Epilepsia"},{"key":"13747_CR32","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/epi.14486","volume":"59","author":"G Kalss","year":"2018","unstructured":"Kalss G, Rohracher A, Leitinger M et al (2018) Intravenous brivaracetam in status epilepticus: a retrospective single\u2010center study. Epilepsia 59:228\u2013233. https:\/\/doi.org\/10.1111\/epi.14486","journal-title":"Epilepsia"},{"key":"13747_CR33","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1111\/epi.14476","volume":"59","author":"A Strzelczyk","year":"2018","unstructured":"Strzelczyk A, Kay L, Bauer S et al (2018) Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus. Epilepsia 59:1549\u20131556. https:\/\/doi.org\/10.1111\/epi.14476","journal-title":"Epilepsia"},{"key":"13747_CR34","doi-asserted-by":"publisher","first-page":"e2021156","DOI":"10.23750\/abm.v92is1.9649","volume":"92","author":"AD De Liso","year":"2021","unstructured":"De Liso AD, Ricci L, Bravi MC et al (2021) An uncommon case of nonconvulsive status epilepticus successfully treated with enteral brivaracetam. Acta Bio Med\u202f: Atenei Parm 92:e2021156. https:\/\/doi.org\/10.23750\/abm.v92is1.9649","journal-title":"Acta Bio Med : Atenei Parm"},{"key":"13747_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-234955","volume":"13","author":"AA Ammar","year":"2020","unstructured":"Ammar AA, Ammar MA, Owusu K, Gilmore EJ (2020) Intravenous brivaracetam for the management of refractory focal non-convulsive status epilepticus. BMJ Case Rep 13:e234955. https:\/\/doi.org\/10.1136\/bcr-2020-234955","journal-title":"BMJ Case Rep"},{"key":"13747_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.seizure.2020.05.015","volume":"80","author":"G d\u2019Orsi","year":"2020","unstructured":"d\u2019Orsi G, Lalla A, Claudio MTD et al (2020) Brivaracetam in absence status epilepticus. Seizure 80:3\u20134. https:\/\/doi.org\/10.1016\/j.seizure.2020.05.015","journal-title":"Seizure"},{"key":"13747_CR37","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1212\/wnl.0b013e3181ec7f7f","volume":"75","author":"JA French","year":"2010","unstructured":"French JA, Costantini C, Brodsky A et al (2010) Adjunctive brivaracetam for refractory partial-onset seizures. Neurology 75:519\u2013525. https:\/\/doi.org\/10.1212\/wnl.0b013e3181ec7f7f","journal-title":"Neurology"},{"key":"13747_CR38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1528-1167.2012.03598.x","volume":"54","author":"WV Paesschen","year":"2013","unstructured":"Paesschen WV, Hirsch E, Johnson M et al (2013) Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial\u2010onset seizures: a phase IIb, randomized, controlled trial. Epilepsia 54:89\u201397. https:\/\/doi.org\/10.1111\/j.1528-1167.2012.03598.x","journal-title":"Epilepsia"},{"key":"13747_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/epi.12432","volume":"55","author":"P Ryvlin","year":"2014","unstructured":"Ryvlin P, Werhahn KJ, Blaszczyk B et al (2014) Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double\u2010blind, randomized, placebo\u2010controlled trial. Epilepsia 55:47\u201356. https:\/\/doi.org\/10.1111\/epi.12432","journal-title":"Epilepsia"},{"key":"13747_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/epi.12433","volume":"55","author":"V Biton","year":"2014","unstructured":"Biton V, Berkovic SF, Abou\u2010Khalil B et al (2014) Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double\u2010blind, placebo\u2010controlled trial. Epilepsia 55:57\u201366. https:\/\/doi.org\/10.1111\/epi.12433","journal-title":"Epilepsia"},{"key":"13747_CR41","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/epi.12391","volume":"55","author":"P Kwan","year":"2014","unstructured":"Kwan P, Trinka E, Paesschen WV et al (2014) Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial. Epilepsia 55:38\u201346. https:\/\/doi.org\/10.1111\/epi.12391","journal-title":"Epilepsia"},{"key":"13747_CR42","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1111\/epi.13212","volume":"56","author":"P Klein","year":"2015","unstructured":"Klein P, Schiemann J, Sperling MR et al (2015) A randomized, double\u2010blind, placebo\u2010controlled, multicenter, parallel\u2010group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial\u2010onset seizures. Epilepsia 56:1890\u20131898. https:\/\/doi.org\/10.1111\/epi.13212","journal-title":"Epilepsia"},{"key":"13747_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2020.106327","volume":"163","author":"BD Moseley","year":"2020","unstructured":"Moseley BD, Chanteux H, Nicolas J-M et al (2020) A review of the drug\u2212drug interactions of the antiepileptic drug brivaracetam. Epilepsy Res 163:106327. https:\/\/doi.org\/10.1016\/j.eplepsyres.2020.106327","journal-title":"Epilepsy Res"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13747-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13747-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13747-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T01:48:52Z","timestamp":1776649732000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13747-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["13747"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13747-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Moses Mo was financially supported by a University of Calgary, Department of Critical Care Medicine, Summer Studentship Scholarship. The remaining authors including Anna Howard, Caralyn Bencsik, Ish Bains, Natalia Jaworska, and Julie Kromm have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"As per institutional policy, this systematic review did not require ethics approval. We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"As per institutional policy, this systematic review did not require patient consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"AI was used to remove duplicate articles after the search, but for no other part of this systematic review, nor manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Artificial intelligence"}}],"article-number":"209"}}